Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)

SHE:301408 Revenue

Anhui Huaren Health Pharmaceutical had revenue of 1.42B CNY in the quarter ending March 31, 2026, with 12.17% growth. This brings the company's revenue in the last twelve months to 5.64B, up 20.17% year-over-year. In the year 2025, Anhui Huaren Health Pharmaceutical had annual revenue of 5.49B with 21.07% growth.

• Revenue (ttm): 5.64B
• Revenue Growth: +20.17%
• P/S Ratio: 1.55
• Revenue / Employee: 711.33K
• Employees: 7,930
• Market Cap: 8.72B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.49B	954.99M	21.07%
Dec 31, 2024	4.53B	734.53M	19.34%
Dec 31, 2023	3.80B	534.74M	16.39%
Jan 1, 2023	3.26B	923.72M	39.50%
Jan 1, 2022	2.34B	407.79M	21.12%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 7, 2026

Data Sources Report a data error